These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21807325)

  • 21. Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).
    Fonarow GC; Lukas MA; Robertson M; Colucci WS; Dargie HJ
    Am Heart J; 2007 Oct; 154(4):637-44. PubMed ID: 17892984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.
    Prasad SK; Dargie HJ; Smith GC; Barlow MM; Grothues F; Groenning BA; Cleland JG; Pennell DJ
    Heart; 2006 Jun; 92(6):798-803. PubMed ID: 16339819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
    Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
    Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
    Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.
    Tatli E; Kurum T; Aktoz M; Buyuklu M
    Int J Cardiol; 2008 Apr; 125(2):273-6. PubMed ID: 18053592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    Angiology; 2008; 59(3):323-8. PubMed ID: 18388105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
    Cardinale D; Colombo A; Lamantia G; Colombo N; Civelli M; De Giacomi G; Rubino M; Veglia F; Fiorentini C; Cipolla CM
    J Am Coll Cardiol; 2010 Jan; 55(3):213-20. PubMed ID: 20117401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 31. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial.
    Heck SL; Gulati G; Ree AH; Schulz-Menger J; Gravdehaug B; Røsjø H; Steine K; Bratland A; Hoffmann P; Geisler J; Omland T
    Cardiology; 2012; 123(4):240-7. PubMed ID: 23207160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.
    Hong YJ; Jeong MH; Hwang SH; Yun NS; Lee SR; Hong SN; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2006 Oct; 70(10):1269-74. PubMed ID: 16998257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.
    Cardinale D; Ciceri F; Latini R; Franzosi MG; Sandri MT; Civelli M; Cucchi G; Menatti E; Mangiavacchi M; Cavina R; Barbieri E; Gori S; Colombo A; Curigliano G; Salvatici M; Rizzo A; Ghisoni F; Bianchi A; Falci C; Aquilina M; Rocca A; Monopoli A; Milandri C; Rossetti G; Bregni M; Sicuro M; Malossi A; Nassiacos D; Verusio C; Giordano M; Staszewsky L; Barlera S; Nicolis EB; Magnoli M; Masson S; Cipolla CM;
    Eur J Cancer; 2018 May; 94():126-137. PubMed ID: 29567630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function.
    Kakavas PW; Ghalie R; Parrillo JE; Kaizer H; Barron JT
    Bone Marrow Transplant; 1995 Jun; 15(6):859-61. PubMed ID: 7581081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].
    Dabrowski R; Pedzich-Placha E
    Kardiol Pol; 2010 Jul; 68(7):810-3; discussion 814. PubMed ID: 20648444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension].
    Iarkova NA; Borovkov NN
    Klin Med (Mosk); 2009; 87(10):25-9. PubMed ID: 20017346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients.
    Awada G; de Azambuja E; Awada A
    Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1205-1215. PubMed ID: 29088977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy.
    Kwon HW; Kwon BS; Kim GB; Chae JH; Park JD; Bae EJ; Noh CI
    Korean Circ J; 2012 Mar; 42(3):184-91. PubMed ID: 22493613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.